OIM
BDSX icon

Oracle Investment Management’s Biodesix BDSX Stock Holding History

Oracle Investment Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,000
Closed -$113K – 23
2025
Q3 		$113K Buy
+15,000
New +$115K 0.07% 20
2024
Q4 		– Sell
-1,446
Closed -$51.5K – 20
2024
Q3 		$51.5K Hold
1,446
– – 0.03% 22
2024
Q2 		$44.2K Sell
1,446
-72
-5% -$2.06K 0.04% 22
2024
Q1 		$43.4K Sell
1,518
-1,529
-50% -$52.3K 0.03% 25
2023
Q4 		$112K Buy
3,047
+943
+45% +$29.6K 0.07% 24
2023
Q3 		$69.4K Buy
+2,104
New +$58.4K 0.02% 21
2021
Q4 		– Sell
-9,042
Closed -$1.49M – 37
2021
Q3 		$1.49M Sell
9,042
-2,734
-23% -$519K 0.19% 26
2021
Q2 		$3.11M Hold
11,776
– – 0.43% 23
2021
Q1 		$4.78M Hold
11,776
– – 0.72% 18
2020
Q4 		$4.19M Buy
+11,776
New +$3.67M 0.53% 14

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Oracle Investment Management's BDSX Position: Q4 2025 in Review

Oracle Investment Management sold out of Biodesix (BDSX) in Q4 2025, closing a stake of 15,000 shares — an estimated $113K sold.

Oracle Investment Management first reported a position in BDSX in Q4 2020 and held it in 10 quarters. The position peaked at $4.78M in Q1 2021. 26 funds tracked by Wall St. Rank hold BDSX as of Q4 2025.

  • Oracle Investment Management reported no remaining Biodesix position as of Q4 2025 after selling out during the quarter.
  • Oracle Investment Management sold 15,000 Biodesix shares in Q4 2025, an estimated $113K.
  • Oracle Investment Management first reported a position in Biodesix in Q4 2020 and held it in 10 quarters.
  • Oracle Investment Management's Biodesix position peaked at $4.78M in Q1 2021.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q4 2025.

Based on Oracle Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.